Novartis Investigative site

Golden, Colorado 80401

0 studies enrolling now · 7 studies all time

What they study most

Age-Related Macular Degeneration, COPD, Chronic Obstructive Pulmonary Disease, Neovascular Age-related Macular Degeneration, Non-infectious Intermediate Uveitis, Non-infectious Panuveitis, Non-infectious Posterior Uveitis, Non-infectious Uveitis, Obesity, Overweight

Studies at this site

• Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections — Stopped early
• Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , — Completed
• Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD — Completed
• A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults — Completed
• Safety and Efficacy of AIN457 in Noninfectious Uveitis — Completed
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed